Chromatographic preparation and kinetic analysis of interactions between tabun enantiomers and acetylcholinesterase

Toxicology Letters

Volumn 195, Issue 2-3, 2010, Pages 142-146

  Tenberken, O ^a   Thiermann, H ^a   Worek, F ^a   Reiter, G ^a  

^a BUNDESWEHR INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (Germany)

Author keywords

Acetylcholinesterase; Enantiomers; Inhibition; Kinetics; Reactivation; Tabun

Indexed keywords

ACETYLCHOLINESTERASE; TABUN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENANTIOMER; ENZYME INHIBITION; ENZYME KINETICS; ENZYME REACTIVATION; ERYTHROCYTE GHOST; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; INHIBITION KINETICS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR INTERACTION; NONHUMAN; OPTICAL ROTATION; PRIORITY JOURNAL; STEREOCHEMISTRY; SWINE; TOXICOKINETICS;

ACETYLCHOLINESTERASE; ANIMALS; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; CHROMATOGRAPHY, LIQUID; HUMANS; KINETICS; PHOSPHORIC ACID ESTERS; STEREOISOMERISM; SWINE;

SUIDAE;

EID: 77952543863     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.03.012     Document Type: Article

References (36)

1. Aldridge W.N., Reiner E. Enzyme Inhibitors as Substrates-Interactions of Esterases with Esters of Organophosphorus and Carbamic Acids 1972, North-Holland Publishing Company, Amsterdam, London.
2. Aurbek N., Thiermann H., Szinicz L., Eyer P., Worek F. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase. Toxicology 2006, 224:91-99.
3. Benschop H.P., de Jong L.P.A. Nerve agent stereoisomers: analysis, isolation, and toxicology. Acc. Chem. Res. 1988, 21:368-374.
4. Benschop H.P., de Jong L.P.A. Toxicokinetics of nerve agents. Chemical Warfare Agents: Toxicity at Low Levels 2001, 25-81. CRC Press, Boca Raton. S.M. Somani, J.A. Romano (Eds.).
5. Boter H.L., Ooms A.J.J., Van den Berg G.R., van Dijk C. The synthesis of optically active isopropyl methylphosphonofluoridate (sarin). Rec. Trav. Chim. Pays-Bas 1966, 85:147-150.
6. Carletti E., Aurbek N., Gillon E., Loiodice M., Nicolet Y., Fontecilla-Camps J.C., Masson P., Thiermann H., Nachon F., Worek F. Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun. Biochem. J. 2009, 421:97-106.
7. Carletti E., Li H., Ekström F., Nicolet Y., Loiodice M., Gillon E., Froment M.T., Lockridge O., Schopfer L.M., Masson P., Nachon F. Aging of cholinesterases phosphylated by tabun proceeds through O-dealkylation. J. Am. Chem. Soc. 2008, 130:16011-16020.
8. Dawson R.M. Review of oximes available for treatment of nerve agent poisoning. J. Appl. Toxicol. 1994, 14:317-331.
9. de Bisschop H.C.J.V., Michiels K.W., Vlaminck L.B.C., Vansteenkiste S.O., Schacht E.H. Phosphonylation of purified human, canine and porcine cholinesterase by soman-stereoselective aspects. Biochem. Pharmacol. 1991, 41:955-959.
10. de Jong L.P.A., Verhagen A.A.V., Langenberg J.P., Hagedorn I., Löffler M. The bispyridinium-dioxime HLö-7: a potent reactivator for acetylcholinesterase inhibited by the stereoisomers of tabun and soman. Biochem. Pharmacol. 1989, 38:633-640.
11. Degenhardt C.E., Van-den Berg G.R., de Jong L.P.A., Benschop H.P. Enantiospecific complexation gas chromatography of nerve agents. Isolation and properties of the enantiomers of ethyl N,N-dimethylphosphoramidocyanidate (tabun). J. Am. Chem. Soc. 1986, 108:8290-8291.
12. Ekström F., Akfur C., Tunemalm A.K., Lundberg S. Structural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase. Biochemistry 2006, 45:74-81.
13. Ekström F., Pang Y.P., Boman M., Artursson E., Akfur C., Borjegren S. Crystal structures of acetylcholinesterase in complex with HI-6, Ortho-7 and obidoxime: structural basis for differences in the ability to reactivate tabun conjugates. Biochem. Pharmacol. 2006, 72:597-607.
14. Eyer P., Worek F. Oximes. Chemical Warfare Agents: Toxicology and Treatment 2007, 305-329. John Wiley & Sons Ltd., Chichester. T.C. Marrs, R.L. Maynard, F.R. Sidell (Eds.).
15. Forsberg A., Puu G. Kinetics for the inhibition of acetylcholinesterase from the electric eel by some organophosphates and carbamates. Eur. J. Biochem. 1984, 140:153-156.
16. Hall C.R., Inch T.D., Lewis G.J., Chittenden R.A. Stereospecific synthesis from carbohydrate precursors of (R)- and (S)-ethyl isopropyl methyl phosphate and other optically active neutral phosphorus esters. Chem. Commun. 1975, 720-721.
17. Harvey S.P., Kolakowski J.E., Cheng T.C., Rastogi V.K., Reiff L.P., DeFrank J.J., Raushel F.M., Hill C. Stereospecificity in the enzymatic hydrolysis of cyclosarin (GF). Enzyme Microb. Technol. 2005, 37:547-555.
18. Jokanovic M., Maksimovic M., Kilibarda V., Jovanovic D., Savic D. Oxime-induced reactivation of acetylcholinesterase inhibited by phosphoramidates. Toxicol. Lett. 1996, 85:35-39.
19. Marrs T.C. Organophosphate poisoning. Pharmacol. Ther. 1993, 58:51-66.
20. Mesic M., Deljac A., Deljac V., Binenfeld Z., Kilibarda V., Maksimovic M., Kovacevic V. Reactivators of acetylcholinesterase inhibited by organophosphorus compounds. Imidazole derivatives. II. Acta Pharmacol. Jugosl. 1991, 41:203-210.
21. Millard C.B., Kryger G., Ordentlich A., Greenblatt H.M., Harel M., Raves M.L., Segall Y., Barak D., Shafferman A., Silman I., Sussman J.L. Crystal structures of aged phosphonylated acetylcholinesterase: nerve agent reaction products at the atomic level. Biochemistry 1999, 38:7032-7039.
22. Nachon F., Nicolet Y., Viguie N., Masson P., Fontecilla-Camps J.C., Lockridge O. Engineering of a monomeric and low-glycosylated form of human butyrylcholinesterase. Eur. J. Biochem. 2002, 269:630-637.
23. Reiter, G, 2004. Interaktionen von Cyclosarin mit verschiedenen Enzym-Systemen. Grundlagen für Überlegungen zur Verbesserung medizinischer Schutzmaßnahmen. Thesis, University Munich.
24. Reiter G., Mikler J., Hill I., Weatherby K., Thiermann H., Worek F. Chromatographic resolution, characterisation and quantification of VX enantiomers in hemolysed swine blood samples. J. Chromatogr. B 2008, 873:86-94.
25. Shafferman A., Ordentlich A., Barak D., Stein D., Ariel N., Velan B. Aging of phosphylated human acetylcholinesterase: catalytic processes mediated by aromatic and polar residues of the active centre. Biochem. J. 1996, 318:833-840.
26. Sussman J.L., Harel M., Frolow F., Oefner C., Goldman A., Toker L., Silman I. Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science 1991, 253:872-879.
27. Taylor P., Radic Z., Hosca N.A., Camp S., Marchot P., Berman H.A. Structural basis for the specificity of cholinesterase catalysis and inhibition. Toxicol. Lett. 1995, 82/83:453-458.
28. Taylor P., Wong L., Radic Z., Tsigelny I., Brüggemann R., Hosea N., Berman H.A. Analysis of cholinesterase inactivation and reactivation by systematic structural modification and enantiomeric selectivity. Chem. Biol. Interact. 1999, 119/120:3-15.
29. Tenberken, O., Worek, F., Thiermann, H., Reiter, G., in press. Development and validation of a sensitive gas chromatography-ammonia chemical ionization mass spectrometry procedure for the determination of tabun enantiomers in blood/plasma of different species. J. Chromatogr. B, ). doi:10.1016/j.jchromb.2009.09.002.
30. Van den Berg G.R., Beck H.C., Benschop H.P. Stereochemical analysis of the nerve agents soman, sarin, tabun, and VX by proton NMR-spectroscopy with optically active shift reagents 42. Bull. Environ. Contam. Toxicol. 1984, 33:505-514.
31. Wang E.I.C., Braid P.E. Oxime reactivation of diethylphosphoryl human serum cholinesterase. J. Biol. Chem. 1967, 242:2683-2687.
32. Wong L., Radic Z., Brüggemann J.M., Hosea N., Berman H.A., Taylor P. Mechanism of oxime reactivation of acetylcholinesterase analyzed by chirality and mutagenesis. Biochemistry 2000, 39:5750-5757.
33. Worek F., Diepold C., Eyer P. Dimethylphosphoryl-inhibited human cholinesterases: inhibition, reactivation, and aging kinetics. Arch. Toxicol. 1999, 73:7-14.
34. Worek F., Mast U., Kiderlen D., Diepold C., Eyer P. Improved determination of acetylcholinesterase activity in human whole blood. Clin. Chim. Acta 1999, 288:73-90.
35. Worek F., Reiter G., Eyer P., Szinicz L. Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates. Arch. Toxicol. 2002, 76:523-529.
36. Worek F., Thiermann H., Szinicz L., Eyer P. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes. Biochem. Pharmacol. 2004, 68:2237-2248.